Freeline Therapeutics Updates Clinical Development Plan for its FLT180a Hemophilia B Program

Plugin JSON Content Importer Pro not running: Check Licence! Check that a Licence is active for https://freeline.life
You might also like
Freeline Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
Freeline To Participate In Conferences During January 2022
Acquisition of Freeline by Syncona Becomes Effective
Freeline Announces June 2022 Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Freeline to Participate in Evercore ISI 4th Annual HealthCONx Conference
Freeline Presents Long-Term Follow-Up Data from Phase 1/2 B-AMAZE Trial in Hemophilia B at the 2021 ASH Annual Meeting and Announces Early Initiation of Phase 1/2 B-LIEVE Dose-Confirmation Trial
Get in touch

+44 (0)1438 906870
contact@freeline.life

Follow us on our social channels